Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Deslorelin effectively treats hair loss in neutered ferrets by reducing hormone levels.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Finasteride reduces hair growth and is safe for women with excessive hair.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Menopause can cause skin issues, and seeing a dermatologist helps.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.